一个病例系列的三个患者与组织学证明后COVID-19组织性肺炎
Cheuk Cheung Derek Leung1, Yiu Cheong Yeung1
1Department of Medicine and Geriatrics Princess Margaret Hospital Kowloon Hong Kong.
Respirology case reports
|September 29, 2023
概括
组织性肺炎是一种肺部疾病,可在COVID-19康复后发展. 早期的皮质类固醇治疗导致了三名患有这种间歇性肺部疾病的患者的良好结果.
科学领域:
- 肺部病理学 肺部病理学
- 病理学 病理学 病理学
背景情况:
- 组织性肺炎是一种间歇性肺部疾病.
- COVID-19 可以导致各种病毒后并发症.
研究的目的:
- 报告COVID-19感染后组织性肺炎的病例.
- 描述组织学发现和治疗结果.
- 为了突出COVID-19恢复的潜在并发症.
主要方法:
- 一系列病例报告了三个患有COVID-19后组织性肺炎的患者.
- 通过横支气管活检进行组织学确认.
- 对持续的皮质类固醇治疗的治疗反应的评估.
主要成果:
- 穿越支气管的活检显示了气泡腔空间中特有的纤维细胞塞.
- 患者接受了长时间的皮质类固醇治疗 (86-166天).
- 这三名患者均表现出组织性肺炎的良好康复.
结论:
- 组织性肺炎是COVID-19后的一个潜在的,可治疗的并发症.
- 皮质类固醇治疗似乎对COVID-19后组织性肺炎有效.
- 组织学确认对于诊断至关重要.
更多相关视频
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
4.9K
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
11.8K
相关概念视频
Pneumonia I: Introduction
262
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
262
Pneumonia II: Pathophysiology
314
The pathophysiology of pneumonia involves the following steps:
314
COPD: Pathogenesis and Clinical Features
327
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
327
Pneumonia III: Complications and Assessment
253
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
253
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Pneumonia IV: Management
353
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
353
